Porto, Portugal
+351 960 245 977
fbnsantos@fbnsantos.com

Category: Corindus

Robotics | IoT

Corindus submits CorPath GRX to FDA for robotic neurovascular interventions

Corindus Vascular Robotics this week said it applied to the U.S. Food and Drug Administration for premarket clearance to use its CorPath GRX robotic surgical platform in neurovascular interventions. The Waltham, Mass.-based company has already received FDA clearance for percutaneous coronary interventions (PCI), which it won in 2016, and for peripheral vascular interventions (PVI), which it won last…

The post Corindus submits CorPath GRX to FDA for robotic neurovascular interventions appeared first on The Robot Report.

Corindus opens first international training center for CorPath GRX System

Corindus Vasular Robotics opened its first international CorPath GRX Robotic Center in Tokyo to educate cardiologists on robotic-assisted percutaneous coronary interventions, the company announced today. “The opening of the first international robotic center represents an important milestone in the process of bringing precision vascular robotics to patients and physicians in Japan and around the world,”…

The post Corindus opens first international training center for CorPath GRX System appeared first on The Robot Report.

Corindus launches post-approval study for CorPath GRX coronary system

Corindus Vascular Robotics announced the first patient enrollment in a post-market study of its second-generation CorPath GRX System, a robot-assisted system for percutaneous coronary interventions such as stenting. “Enrollment of the first patient in the Precision GRX registry is a major milestone for the company and we look forward to the participation of leading centers…

The post Corindus launches post-approval study for CorPath GRX coronary system appeared first on The Robot Report.